Skip to content
Specimen Atlas of Research Peptides85 plates · MIT
← CataloguePlate 61 of 85

C15H26N6O8 · 418.4 g/mol · PubChem CID 10273502

61Plate 61Reviewed 2026-04-25

Pinealon

Tetrapeptide bioregulator

also known as Glu-Asp-Arg, EDR

Synthetic tetrapeptide (Glu-Asp-Arg) developed at the Saint Petersburg Institute of Bioregulation and Gerontology. Russian literature reports neuroprotective and antioxidant effects, particularly in age-related cognitive decline. Limited Western RCT data. Frequently used anecdotally for cognitive support and longevity, often in combination with Epitalon.

Quick facts
Class
Tetrapeptide bioregulator
Evidence level
Human mechanistic evidence
Regulatory status
Not FDA-approved (US) — research use only
§ I

At a glance

Per cycle dose
5–10 mg
Half-life (est)
Hours
Route

SQ or IM · Daily for 10 days · 1-2×/year

§ II

Mechanism

Edit ↗

Primary target — Antioxidant defense + neuronal gene expression (proposed) [khavinson-2014-pinealon].

Pathway — Modulation of antioxidant enzymes (SOD, catalase) + neurotrophic factor expression [khavinson-2014-pinealon].

Downstream effect — Reduced oxidative stress in neurons; improved cognitive function in age-related decline [khavinson-2014-pinealon].

Origin — Synthetic 4-AA peptide derived from pineal gland extract [khavinson-2014-pinealon].

§ III

Dosage

Protocols described in the cited literature; not medical advice.

Edit ↗
ParameterValue
Standard dose5–10 mg / day for 10 days [khavinson-2014-pinealon]
FrequencyOnce daily during cycle
Lower / starter dose2.5 mg / day
Evidence basisRussian clinical trials + in vitro [khavinson-2014-pinealon]
Duration10-day cycles, 1–2× per year
ReconstitutionBacteriostatic water
TimingNo specific time
Half-lifeHours
§ III · b

Reconstitution

A pure mass-to-volume utility. Enter what you have in the vial; the atlas computes the volume per dose. No prescription information.

Inputs
mg
mL
mcg
The calculator does pure mass-to-volume math. It does not recommend a dose. Refer to Pinealon's cited literature for protocol specifics.
Volumetric outputFig. C — reconstitution math
Volume per dose
0.050mL
5.0 units on a U-100 insulin syringe
Concentration
5000
mcg per mL
Doses per vial
40
at this dose
§ V

Adverse events

Severities follow the FDA / CTCAE convention.

Edit ↗
Injection site reactionmild
Mild irritation
Long-term safetymoderate
Limited Western data
Pregnancy / OBsevere
Avoid
Absolute contraindications
  • Pregnancy / breastfeeding
Relative contraindications
  • Active malignancy (theoretical via gene expression modulation)
§ VI

Administration

Edit ↗
  1. 01
    Reconstitution

    Add 1–2 mL bacteriostatic water to 10 mg vial.

  2. 02
    Injection site

    SQ — abdomen preferred.

  3. 03
    Timing

    Daily during cycle, any time.

  4. 04
    Storage

    Lyophilised: room temp. Reconstituted: refrigerate ≤30 days.

  5. 05
    Needle

    29–31G, 4–8 mm insulin syringe.

§ VII

Synergies

Edit ↗
Reference Q&A

Frequently asked

How does Pinealon work?

Pinealon acts on Antioxidant defense + neuronal gene expression (proposed), signalling via Modulation of antioxidant enzymes (SOD, catalase) + neurotrophic factor expression. [khavinson-2014-pinealon][khavinson-2014-pinealon]

Is Pinealon FDA-approved?

Pinealon is not FDA-approved in the United States and is handled as a research compound (research use only). Regulatory status may differ in other jurisdictions.

Appendix

Sources

22%

of 36 rendered claims carry a resolvable citation.

  1. [khavinson-2014-pinealon]
    Khavinson 2014Tetrapeptide pinealon: neuroprotective and antioxidant effects
    Bull Exp Biol Med, 2014
    Pinealon (Glu-Asp-Arg) Russian peptide bioregulator — neuroprotection.
Related plates
Plate composed 2026-04-25 · maturity auto-drafted · schema v1 · Contributors: peptidesdb-core · 28 fields uncited — open contributions